The Epstein-Barr virus (EBV) open reading frame (ORF) BCRF1, expressed in the late phase of the viral cycle, encodes a homologue of human intedeukin-10 (hlL-10). Unspliced, 3' co-terminal transcripts of 0-8 and 1.6kb from O-tetradecanoylphorbol 13-acetate (TPA)-treated B95-8 cells have been described but other results indicated the existence ofuncharacterized transcript(s) initiated upstream of the 1.6 kb BCRF1 mRNA. Here we describe two additional large transcripts of the BCRF10RF, a possibly spliced product of 3-5 kb and an unspliced product of 4.5 kb. The time course of the expression of BCRF1 transcripts and of the secreted protein from Akata cells were also determined.
The product of Epstein-Barr virus (EBV) open reading frame (ORF) BCRF1 which is expressed in the late phase of the viral life cycle, is 84 % homologous at the amino acid level with mature human interleukin-10 (hIL-10) (Vieira et al., 1991) . This cytokine has been described as an immunoregulatory protein which could play a major role as a suppressor of immune and inflammatory responses (for a review see Moore et al., 1993) . BCRF1 protein, also termed viral , inhibits the synthesis of cytokines [interferon (IFN)-? and IL-2] by activated T helper 1 cell clones (TH1) and induces both the ctonal expansion of activated human B cells and their maturation into Ig-secreting cells (Rousset et al., 1992) . All these properties might enhance viral survival in the host, since EBV infects B cells and IFN-7 is a major host defence against EBV transformation of B cells (Lotz et al., 1985) .
Unspliced transcripts of the BCRF10RF from Otetradecanoylphorbol 13-acetate (TPA)-treated B95-8 cells, have been described (Hudson et al., 1985; Lau et al., 1993) : a 0"8 kb mRNA (which could be initiated from the BCR1 promoter) and a 1.6 kb transcript. Both mRNAs have a common 3' end. Results reported by Lau et al. (1993) indicated the existence of uncharacterized transcript(s) initiated upstream of the 1"6 kb BCRF1 transcript. Besides, a report from Stewart et al. (1994) described the expression of an additional 1 kb BCRF1 transcript from induced B95-8 and Akata cells.
A 2-ZAP cDNA library (Stratagene) was prepared using poly(A) + RNA from TPA-treated B95-8 cells. This * Author for correspondence. Fax + 33 1 45 59 70 09. e-mail ijoab@igr.fr library was screened with a probe covering the whole BCRF1 sequence. Four polyadenylated cDNAs (F1, F2, F3 and F4) were isolated. Sequencing of approximately 100 bp of both 5' and 3' ends and restriction analysis of the four cDNAs were performed; they differed only in the extent of their 5' region. The cDNAs ranged respectively from 9247, 8843, 8770 and 8561 to 10280 and were collinear with the EBV genome (Fig. 1 a) . All the cDNAs contained poly(A) tracts at the Y end, confirming that they were derived from mRNAs; they may represent partial copies of BCRF1 transcripts. Polyadenylation occurs 18 bases after the consensus site AATAAA confirming the observation of Hudson et al. (1985) . All these cDNAs were unspliced and presented the same 3' end which has already been determined for the 0'8 and 1.6 kb mRNAs. The F4 cDNA (1719 bp) is longer than the other BCRF1 mRNAs previously described (Hudson et al., 1985; Lau et al., 1993) . The 5' end (8561) of this cDNA was located upstream of the initiation point (8708) of the 1.6 kb mRNA described by Lau et al. (1993) .
Transcription of BCRF1 gene was investigated by Northern blotting. Northern blotting was performed with total RNA from Akata cells (RNAzol B method; Biotecx Laboratories) treated with rabbit anti-human IgG antibodies (1% v/v; Dakopatts A424). Akata cells were chosen because the disruption of latency by antihuman IgG antibodies treatment is followed by a dramatic and synchronous increase in cells positive for lytic antigens (Takada & Ono, 1989 (Hudson et al., 1985) IP I (Lau et al., 1993) All co-ordinates are given relative to the B95-8 EBV map (Baer et al., 1984) . Full boxes indicate both 5' and 3' ends which were sequenced. The 21 x 30 bp repeat, the 65 bp palindrome contained in the orz~ region, the origin for plasmid replication (Yates et aL, 1984) are shown. The BCRF1 reading frame (9675 to 10184), preceded by a potential BCR1 promoter (9631) and followed by a potential polyadenylation signal (10257) are represented. The BCRFI transcripts (0"8 kb and 1.6 kb) described respectively by Hudson et al. (1985) and Lau et aL (1993) Northern blotting performed with poly(A) + RNA obtained from TPA-treated B95-8 cells exhibit the same pattern. Nevertheless, the bands were less visible (data not shown).
To characterize the 5' regions of the 3-5 and 4.5 kb BCRF1 transcripts, we performed Northern blotting using probes located upstream of the 1.6 kb BCRF1 transcript. The 2AS probe (8468 to 8112), located just downstream of the Family Repeat (FR) sequence (represented in Fig. 1 b) , hybridized with the larger (3.5 and 4.5 kb) BCRF1 transcripts [ Fig. 1 c, panel (ii) ]. On the contrary, the 3AS (8029 to 7447) and 4AS (7418 to 7032) probes, located respectively within and just upstream of the FR, failed to hybridize with the 3"5 kb transcript [ Fig. 1 c, panels (iii) and (iv) respectively]. Hybridization with the 3AS probe, lying within the FR region [ Fig. l c, panel (iii) ] exhibited a weak signal probably due to the structure of this sequence. The lack of detection of the 3-5 kb transcript with the 3AS probe is unlikely to be due to difficulties of hybridization with this probe, since the 4.5 kb transcript which was less abundant than the 3.5 kb one [ Fig. 1 c, panels (i) and (ii)], was clearly detected [ Fig. 1 c, panel (iii) ]. This might indicate that the 3.5 kb transcript undergoes at least one splicing event.
The 4-5 kb transcript remained visible not only with the 3AS but also with the 4AS probes. Northern blotting with probes located upstream the 4AS probe gave the same pattern, indicating that the sequence of the 4.5 kb BCRF1 transcript is collinear to the genomic sequence (data not shown).
To further characterize the 5' end of the large transcript, S1 mapping, was performed as previously described by Giot et al. (1991) , with a 5' a~P-labelled probe (AS 6141 to 5752) across the predicted 5' end of the 4'5 kb BCRF1 transcript. The results are shown in Fig. 2 (a) : a strongly protected fragment of 280 bases, restricted to the anti-IgG-treated RNA, is consistent with a 5' end near 5860 (Fig. 2b) . A sequence (TATTTA) about 36 bp upstream of this point, could serve as a TATA box (represented in Fig. 2b ). All the results presented here (the length of the RNA, Northern blotting and S1 mapping) indicated that the 4.5kb BCRF1 transcript is collinear to the genomic sequence (5860 to 10280). A weakly protected band of 350 bases (Fig. 2a) was also observed, possibly corresponding to a small proportion of transcripts which were initiated 5' of the boundary mapped at 5860. The full-length protected band (Fig. 2a ) may correspond to transcripts covering both BNRF1 and downstream sequence (represented in Fig. 2b ) previously described by Hudson et al. (1985) .
The induction time course of the BCRF1 transcripts was determined in anti-IgG-treated Akata cells, by Northern blot hybridized with the IAS ssDNA probe. As shown in Fig. 3 (a) , the four transcripts were detected at 9 h post-induction. The maximum yield of the three larger BCRF 1 transcripts was reached 9 h after treatment and the level remained unchanged over the next 15 h. The 0.8 kb transcript was detected at 6 h post-induction. The maximum yield of this transcript was also reached 9 h post-treatment, was unchanged for the next 3 h, strongly decreased 3 h later and remained unchanged from 15 to 24 h post-treatment.
Immunoprecipitation was performed on the supernatants of the anti-IgG-treated Akata cells. Samples corresponding to 2 x 10 ~ cells were removed at different times after induction (h) and supernatants were immunoprecipitated with a rabbit anti-vlL-10 polyclonal serum (499) raised in our laboratory. Immunoprecipitated complexes were loaded onto 15 % SDS-PAGE, Western blotted, probed with the same 499 serum and revealed with 125I-labelled Protein A. The results are shown in Fig.  3 (b) . vIL-10 was detected 9 h after induction of the lytic cycle. The maximal yield was reached 12 h post-induction and the level remained unchanged from 12 to 24 h after induction of the lytic cycle.
We isolated four 3' co-terminal polyadenylated cDNAs containing the BCRF10RF from a cDNA library constructed with polyadenylated RNA extracted from TPA-treated B95-8 cells. The size of the four cDNAs indicated that all of them correspond to copies of mRNA initiated upstream of the putative BCR1 promoter. Thus, none could be compatible with copies of the 0"8 kb BCRF1 message, although Northern blotting indicates that the 0.8 kb transcript is abundant in TPAtreated cells. Interestingly, Lau et aL (1993) did not detect either any cDNA from oral hairy leukoplakia (OHL) corresponding to the 0.8 kb mRNA. The F1-3 cDNAs could correspond to copies of the 1.6 kb message which was determined to be unspliced by Lau et al. (1993) , contradicting the results of Hudson et al. (1985) . The sequence and the structure of the F4 cDNA shows that, transcript(s) are initiated upstream of the 1"6 kb message. Thus, our results confirm the inference, made from Sl mapping, of the existence of uncharacterized additional mRNA(s) initiated upstream of 8708 (Lau et al. 1993) .
Northern blot analysis performed with RNA prepared from anti-IgG-treated Akata cells, showed that at least four late transcripts bear the BCRF1 open reading frame. In addition to the already described 0"8 and 1.6 kb bands, two other bands migrating at 3'5 and 4.5 kb could be clearly observed in anti-IgG-treated Akata cells. These bands were less visible in Akata and B95-8 TPAtreated cells (data not shown). The fact that Stewart et al. (1994) did not observe transcripts larger than 1.6 kb in Akata cells, may be due to the differences of treatment used to induce the lytic cycle. Similarly, in our experiments the 1 kb transcript is less important which may be due to the difference in inducing agent of the lyric cycle. The large BCRF1 transcripts of 3-5 and 4"5 kb could explain the existence of F4 cDNA isolated from B95-8 cDNA library.
Northern blotting performed with probes covering regions located either upstream or downstream of the FR indicated, surprisingly, that within the 3"5kb transcript, a splicing event might occur in this region. Experiments using rapid amplification of 5' cDNA ends allowed us to isolate clones in which the FR sequence was 'scrambled' (data not shown). This may be due to the structure of the mRNA within the FR which may contain a strong stop signal for the reverse transcriptase. The 4"5 kb transcript which is collinear with the EBV genome contained the whole FR region. No other transcripts have been described in this region. It seemed to be initiated just upstream of the polyadenylation signal of the BNRF1 mRNA and also overlapped the EBERs encoding region.
The time course expression of the 0-8 kb transcript differs from the larger ones since its production peaked at 9 12 h post-anti-IgG treatment followed by a gradual decrease in the amount of the 0.8 kb message. The level of the other 3 mRNAs remained stable as of 9 h postinduction of the lytic cycle.
Although the 0"8 kb transcript was visible as early as 6 h post-induction, the vlL-10 protein was only detected at 9 h after addition of anti-IgG. The vlL-10 protein was therefore detected when the large transcripts were observed. This might indicate that at least one of the large mRNAs could be translated. A possible alternative could be that the detection of protein could be due to the accumulation of translated product of the 0"8 kb message. The state level of vlL-10 production in the culture medium was not further explored. This cytokine produced by EBV-infected cells, might play a role in the EBV-host relationship during the lytic phase of its life cycle.
